About the nasal vaccine being developed by Bharat Biotech after its Coavaxin, Dr Krishna Ella said that the Phase 2 trials are done and data was being analysed. "We should expect it in 3-4 months," he said, adding that Bharat Biotech was also talking to the government about using the Cowin platform for doing clinical trials.
from Zee News :India National https://ift.tt/3D7U6nI
There are many variations of passages of Lorem Ipsum available, but the majority have suffered alteration in some form, by injected humour, or randomised words.
0 Comments